166 related articles for article (PubMed ID: 26306290)
1. A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.
Weinberg RS; Grecco MO; Ferro GS; Seigelshifer DJ; Perroni NV; Terrier FJ; Sánchez-Luceros A; Maronna E; Sánchez-Marull R; Frahm I; Guthmann MD; Di Leo D; Spitzer E; Ciccia GN; Garona J; Pifano M; Torbidoni AV; Gomez DE; Ripoll GV; Gomez RE; Demarco IA; Alonso DF
Springerplus; 2015; 4():428. PubMed ID: 26306290
[TBL] [Abstract][Full Text] [Related]
2. Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial.
Iseas S; Roca EL; O'Connor JM; Eleta M; Sanchez-Luceros A; Di Leo D; Tinelli M; Fara ML; Spitzer E; Demarco IA; Ripoll GV; Pifano M; Garona J; Alonso DF
Invest New Drugs; 2020 Oct; 38(5):1580-1587. PubMed ID: 32166534
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Chuit R; Turdó K; Blanco A; Lazzari MA
Thromb Haemost; 2010 Nov; 104(5):984-9. PubMed ID: 20886181
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade.
Hermo GA; Turic E; Angelico D; Scursoni AM; Gomez DE; Gobello C; Alonso DF
J Am Anim Hosp Assoc; 2011; 47(1):21-7. PubMed ID: 21164169
[TBL] [Abstract][Full Text] [Related]
5. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
Federici AB
Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease.
Guddati AK; Rosovsky RP; Van Cott EM; Kuter DJ
Int J Lab Hematol; 2019 Jun; 41(3):325-330. PubMed ID: 30735311
[TBL] [Abstract][Full Text] [Related]
7. Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin.
Trummer A; Haarmeijer B; Werwitzke S; Wermes C; Ganser A; Budde U; Tiede A
Haemophilia; 2013 Mar; 19(2):236-41. PubMed ID: 23051555
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen.
Ghosh S; Rao AK
Thromb Res; 1993 Jun; 70(5):417-22. PubMed ID: 7690994
[TBL] [Abstract][Full Text] [Related]
9. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
11. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
12. Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation.
Giron S; Tejera AM; Ripoll GV; Gomez DE; Alonso DF
J Surg Oncol; 2002 Sep; 81(1):38-44. PubMed ID: 12210026
[TBL] [Abstract][Full Text] [Related]
13. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
14. Effect of desmopressin acetate on bleeding times and plasma von Willebrand factor in Doberman pinscher dogs with von Willebrand's disease.
Kraus KH; Turrentine MA; Jergens AE; Johnson GS
Vet Surg; 1989; 18(2):103-9. PubMed ID: 2786279
[TBL] [Abstract][Full Text] [Related]
15. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.
Sharma R; Stein D
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016
[TBL] [Abstract][Full Text] [Related]
16. Repeated infusions of DDAVP induce low response of FVIII and vWF but not of plasminogen activators.
Vicente V; Estellés A; Laso J; Moraleda JM; Rivera J; Aznar J
Thromb Res; 1993 Apr; 70(2):117-22. PubMed ID: 8322282
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
Kaufmann JE; Oksche A; Wollheim CB; Günther G; Rosenthal W; Vischer UM
J Clin Invest; 2000 Jul; 106(1):107-16. PubMed ID: 10880054
[TBL] [Abstract][Full Text] [Related]
18. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
Cattaneo M; Simoni L; Gringeri A; Mannucci PM
Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.
Ripoll GV; Farina HG; Yoshiji H; Gomez DE; Alonso DF
In Vivo; 2006; 20(6B):881-5. PubMed ID: 17203783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
